To access this element change to forms mode OFF
Grant Award View - GA217929
Evaluating the efficacy of psilocybin-assisted psychotherapy in...
GA ID:
GA217929
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 8-Sep-2026
Value (AUD):
$2,727,173.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Evaluating the efficacy of psilocybin-assisted psychotherapy in treatment resistant depression
Purpose:
Psychedelic assisted psychotherapy using psilocybin, has been investigated in several small studies for its capacity to aid in the recovery of patients with depression. This form of treatment appears to have antidepressant benefits but there are considerable limitations with the studies that have been conducted today date. We aim to conduct a substantive study evaluating the use of this treatment in patients with depression who have failed to respond to other antidepressant medications.
GO ID:
GO Title:
MRFF - Clinical Trials Activity Initiative - 2021 Innovative Therapies for Mental Illness - Grant Opportunity
Internal Reference ID:
2021/MRF2014381
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Monash University
Recipient ABN:
12 377 614 012
Grant Recipient Location
Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA